Sheldon Tobe
University of Toronto
H-index: 73
North America-Canada
Top articles of Sheldon Tobe
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
La dénervation rénale dans le traitement de l’hypertension non contrôlée | CMAJ | Erez Marcusohn Sheldon W Tobe Andrew Dueck Mina Madan | 2024/2/5 |
Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE trials | Diabetes Care | Sheldon W Tobe Thomas A Mavrakanas Harpreet S Bajaj Adeera Levin Navdeep Tangri | 2024/1/22 |
Outcomes with finerenone in participants with stage 4 CKD and type 2 diabetes: a FIDELITY subgroup analysis | Clinical Journal of the American Society of Nephrology | Pantelis Sarafidis Rajiv Agarwal Bertram Pitt Christoph Wanner Gerasimos Filippatos | 2023/5/1 |
COST-EFFECTIVENESS OF RADIOFREQUENCY RENAL DENERVATION FOR TREATMENT OF UNCONTROLLED HYPERTENSION: A CANADIAN PERSPECTIVE | Canadian Journal of Diabetes | R Feldman A Ryschon K Cao H Sadri S Tobe | 2023/11/1 |
International consensus on standardized clinic blood pressure measurement–a call to action | The American Journal of Medicine | Alfred K Cheung Paul K Whelton Paul Muntner Aletta E Schutte Andrew E Moran | 2023/5/1 |
Association of prior outpatient diabetes screening with cardiovascular events and mortality among people with incident diabetes: a population-based cohort study | Cardiovascular Diabetology | Calvin Ke Anna Chu Baiju R Shah Sheldon Tobe Karen Tu | 2023/8/28 |
Characterizing Hypertension Specialist Care in Canada: A National Survey | CJC open | Samantha Lui Lisa Dubrofsky Nadia A Khan Sheldon W Tobe Jessica Huynh | 2023/12/1 |
Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE | Diabetes, Obesity and Metabolism | Michael A Tsoukas Vincent Woo Sheldon W Tobe April Slee Wally Rapattoni | 2023/7 |
Ups and downs of hypertension control in Canada: critical factors and lessons learned | Norm RC Campbell Raj Padwal Ross T Tsuyuki Alexander A Leung Alan Bell | 2023/4/28 | |
Risk of chronic kidney disease in hospitalized patients with hidradenitis suppurativa | Dermatology | Nouf Almuhanna Sheldon W Tobe Raed Alhusayen | 2023/12 |
Ligne directrice C-CHANGE pour l’harmonisation des lignes directrices nationales de prévention et de prise en charge des maladies cardiovasculaires en contexte de soins … | CMAJ | Rahul Jain James A Stone Gina Agarwal Jason G Andrade Simon L Bacon | 2023/1/9 |
Evaluation of visual acuity in dry AMD patients after microcurrent electrical stimulation | International Journal of Retina and Vitreous | Kevin M Parkinson Eric C Sayre Sheldon W Tobe | 2023/6/18 |
Renal denervation for uncontrolled hypertension | CMAJ | Erez Marcusohn Sheldon W Tobe Andrew Dueck Mina Madan | 2023/11/6 |
Patient perspectives on a pilot virtual follow-up program after hypertensive disorders of pregnancy: a qualitative study | CJC open | Lisa Dubrofsky Serena Gundy Lisa Boesch Katie Poolman Kara A Nerenberg | 2023/6/1 |
COVID-R3ISCSAB: COVID-19 Wide Impact Research on the Risk and Resilience in Special Communities of Chinese, South Asian and Black Populations | Sayna Bahraini Peter Liu Kelly Cobey Heather Tulloch Karen Bouchard | 2023/11/1 | |
Early Changes of Kidney Function Are a Tell for Heart Disease Risk | Sheldon W Tobe | 2022/11/1 | |
856-P: Cardiovascular (CV) and Kidney Outcomes with Canagliflozin (CANA) According to Type 2 Diabetes (T2D) Treatment Targets at Baseline (BL): Data from the CANVAS Program and … | Diabetes | Vincent C Woo Michael Tsoukas Sheldon Tobe April Slee Wally Rapattoni | 2022/6/1 |
Canadian Medical Education Journal | Eric Wooltorton Edward Seale Denice Lewis Kendall Noel Clare Liddy | 2020 | |
Derivation and external validation of a clinical model to predict heart failure onset in patients with incident diabetes | Diabetes Care | Louise Y Sun Salwa S Zghebi Anan Bader Eddeen Peter P Liu Douglas S Lee | 2022/11/1 |
Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long‐Term Response to Atrasentan in Patients With Diabetic Kidney Disease | Clinical Pharmacology & Therapeutics | J David Smeijer Jeroen V Koomen Donald E Kohan John JV McMurray George L Bakris | 2022/11 |
Co-Authors
